Skip to main content
. Author manuscript; available in PMC: 2011 Mar 15.
Published in final edited form as: Immunogenetics. 2010 Apr 13;62(6):345–356. doi: 10.1007/s00251-010-0439-y

Table 2.

Levels of IL-12p40 and IFN-γ in uncomplicated and severe malaria, and non-hyperparasitaemia vs. hyperparasitaemia.

All Study Participants Severe Malaria Patients

UM SM p Non-hyperparasitaemia Hyperparasitaemia p
IL-12p40 (pg/mL), median (IQR) 27.0 (10.0–98.8) 95.1 (27.6–133.1) 0.049 35.1 (12.5–103.9) 121.9 (43.3–163.3) 0.046
  sample size 56 25 14 11
IFN-γ (pg/mL), median (IQR) 283.5 (118.5–473.5) 387.0 (144.2–632.0) 0.051 333.0 (136.7–580.2) 486.0 (153.0–710.5) 0.228
  sample size 106 75 42 33

Patients with P. falciparum infection were categorized as uncomplicated or severe malaria according to WHO criteria (WHO, 2000). Patients with severe malaria were further stratified as non- hyperparasitaemia (<250,000 parasites/µL) and hyperparasitaemia (≥250,000 parasites/µL). IL-12p40 and IFN-γ were measured in those subjects with adequate volumes of available plasma samples. Results are presented as median and interquartile range (IQR), with p≤0.05 considered statistically significant. Mann-Whitney U test was used to compare cytokine levels between the disease conditions.